Fos expression in intrastriatal striatal grafts: regulation by host dopaminergic afferents

Brain Res. 1992 Jun 26;583(1-2):207-15. doi: 10.1016/s0006-8993(10)80026-5.

Abstract

Previous studies have shown that transplants of fetal striatum, implanted into the ibotenic acid-lesioned striatum of adult rats, become innervated from the host nigrostriatal dopamine (DA) pathway. In the present study we have used DA-receptor-mediated expression of the Fos protein (i.e. the product of the immediate-early c-fos gene) as a cellular marker for functional dopaminergic host-graft interactions in the striatal grafts. Amphetamine (5 mg/kg; 2 h) induced Fos-like immunoreactivity in clusters of cells located mainly within the DARPP-32-positive areas within the transplants, i.e. within the striatum-like graft compartment which is preferentially innervated by the host DA afferents. As in the normal striatum, this effect was largely, although not completely, abolished by a 6-hydroxydopamine lesion of the ipsilateral nigrostriatal DA pathway. Apomorphine (0.25 mg/kg; 2 h) had no detectable effect in grafts with an intact host DA system. Two to 3 weeks after a 6-OHDA lesion of the host DA pathway (i.e. a time sufficient for DA receptor supersensitivity to develop), apomorphine-induced extensive Fos-activation selectively within the DARPP-32-positive areas of the graft. The magnitude of the response was similar to that seen in the DA-denervated host striatum. Dual Fos/DARPP-32 immunostaining revealed that the activated graft neurons were, at least in part, DARPP-32-positive. In intrastriatal grafts of fetal neocortical tissue, which were studied for comparison, the amphetamine- and apomorphine-induced effects on Fos expression were much smaller and similar to that seen in the DARPP-32-negative, non-striatal compartment within the striatal grafts.(ABSTRACT TRUNCATED AT 250 WORDS)

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Afferent Pathways / drug effects
  • Afferent Pathways / physiology*
  • Animals
  • Apomorphine / pharmacology*
  • Brain Tissue Transplantation / physiology*
  • Corpus Striatum / pathology
  • Corpus Striatum / physiology*
  • Corpus Striatum / transplantation*
  • Dextroamphetamine / pharmacology*
  • Dopamine / physiology*
  • Dopamine and cAMP-Regulated Phosphoprotein 32
  • Female
  • Fetal Tissue Transplantation / physiology
  • Genes, fos*
  • Ibotenic Acid / toxicity
  • Immunohistochemistry
  • Nerve Tissue Proteins / analysis
  • Nerve Tissue Proteins / metabolism*
  • Oxidopamine / toxicity
  • Phosphoproteins / metabolism
  • Proto-Oncogene Proteins c-fos / analysis
  • Proto-Oncogene Proteins c-fos / metabolism*
  • Rats
  • Rats, Inbred Strains
  • Substantia Nigra / physiology*

Substances

  • Dopamine and cAMP-Regulated Phosphoprotein 32
  • Nerve Tissue Proteins
  • Phosphoproteins
  • Proto-Oncogene Proteins c-fos
  • Ibotenic Acid
  • Oxidopamine
  • Apomorphine
  • Dextroamphetamine
  • Dopamine